These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 23485065
1. Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor. Weiss DR, Ahn S, Sassano MF, Kleist A, Zhu X, Strachan R, Roth BL, Lefkowitz RJ, Shoichet BK. ACS Chem Biol; 2013 May 17; 8(5):1018-26. PubMed ID: 23485065 [Abstract] [Full Text] [Related]
2. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study. Kooistra AJ, Leurs R, de Esch IJ, de Graaf C. J Chem Inf Model; 2015 May 26; 55(5):1045-61. PubMed ID: 25848966 [Abstract] [Full Text] [Related]
3. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening? Tang H, Wang XS, Hsieh JH, Tropsha A. Proteins; 2012 Jun 26; 80(6):1503-21. PubMed ID: 22275072 [Abstract] [Full Text] [Related]
4. Structural features of β2 adrenergic receptor: crystal structures and beyond. Bang I, Choi HJ. Mol Cells; 2015 Jun 26; 38(2):105-11. PubMed ID: 25537861 [Abstract] [Full Text] [Related]
11. Mapping functional group free energy patterns at protein occluded sites: nuclear receptors and G-protein coupled receptors. Lakkaraju SK, Yu W, Raman EP, Hershfeld AV, Fang L, Deshpande DA, MacKerell AD. J Chem Inf Model; 2015 Mar 23; 55(3):700-8. PubMed ID: 25692383 [Abstract] [Full Text] [Related]
12. Modeling G protein-coupled receptors in complex with biased agonists. Costanzi S. Trends Pharmacol Sci; 2014 Jun 23; 35(6):277-83. PubMed ID: 24793542 [Abstract] [Full Text] [Related]
13. Studies on the interactions between β2 adrenergic receptor and Gs protein by molecular dynamics simulations. Feng Z, Hou T, Li Y. J Chem Inf Model; 2012 Apr 23; 52(4):1005-14. PubMed ID: 22404225 [Abstract] [Full Text] [Related]
15. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation. Staus DP, Strachan RT, Manglik A, Pani B, Kahsai AW, Kim TH, Wingler LM, Ahn S, Chatterjee A, Masoudi A, Kruse AC, Pardon E, Steyaert J, Weis WI, Prosser RS, Kobilka BK, Costa T, Lefkowitz RJ. Nature; 2016 Jul 21; 535(7612):448-52. PubMed ID: 27409812 [Abstract] [Full Text] [Related]
16. Modeling GPCR active state conformations: the β(2)-adrenergic receptor. Simpson LM, Wall ID, Blaney FE, Reynolds CA. Proteins; 2011 May 21; 79(5):1441-57. PubMed ID: 21337626 [Abstract] [Full Text] [Related]
17. Ligand-binding affinity of alternative conformers of human β2 -adrenergic receptor in the presence of intracellular loop 3 (ICL3) and their potential use in virtual screening studies. Dilcan G, Doruker P, Akten ED. Chem Biol Drug Des; 2019 May 21; 93(5):883-899. PubMed ID: 30637937 [Abstract] [Full Text] [Related]
18. Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library. Männel B, Jaiteh M, Zeifman A, Randakova A, Möller D, Hübner H, Gmeiner P, Carlsson J. ACS Chem Biol; 2017 Oct 20; 12(10):2652-2661. PubMed ID: 28846380 [Abstract] [Full Text] [Related]
19. GPCR agonist binding revealed by modeling and crystallography. Katritch V, Abagyan R. Trends Pharmacol Sci; 2011 Nov 20; 32(11):637-43. PubMed ID: 21903279 [Abstract] [Full Text] [Related]